Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

591
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
591
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

532
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
532
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

598
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
598
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

478
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
478
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

621
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
621
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

367
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
367

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Endometrial ablation with thermal balloon, experience in a private hospital].

Ginecologia y obstetricia de Mexico·2016
Same author

[Mammographic and ultrasonographic BIRADS classification and its correlation with histopathologic findings].

Ginecologia y obstetricia de Mexico·2016
Same author

[Factors related to the recognition of alarm signals during pregnancy].

Ginecologia y obstetricia de Mexico·1996
Same author

Bacterial vaginosis associated with G vaginallis / Mobiluncus sp: ultrastructural parameters.

Archives of AIDS research·1992
Same author

[Neurophysiologic profile of the high-risk newborn infant in follow-ups].

Boletin medico del Hospital Infantil de Mexico·1986

Related Experiment Video

Updated: Feb 14, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.5K

[Peripartum cardiomyopathy: a case report].

S Karchmer-Krivitzky, R Espinosa-Fernández, A Sánchez-Aranda

    Ginecologia Y Obstetricia De Mexico
    |February 10, 2018
    PubMed
    Summary

    Peripartum cardiomyopathy, a rare heart failure in pregnant women, requires prompt multidisciplinary management. This case highlights successful intervention for this condition, improving patient prognosis.

    Area of Science:

    • Cardiology
    • Maternal-Fetal Medicine
    • Heart Failure Research

    Background:

    • Peripartum cardiomyopathy (PPCM) is an idiopathic heart failure affecting women in late pregnancy or early postpartum.
    • Defined by the European Society of Cardiology as left ventricular failure (ejection fraction ≤45%) without other identifiable causes.
    • PPCM presents between the third trimester and five months after delivery, with historical recognition dating back to 1849.

    Observation:

    • A 39-year-old patient presented with PPCM in early puerperium.
    • Symptoms included hypertension, tachycardia, dyspnea, and oxygen desaturation.
    • Transesophageal echocardiogram revealed heart failure with a hypokinetic left ventricle and ejection fraction <40%.

    Findings:

    • The patient's heart failure was attributed to PPCM, with no other identifiable cause.

    More Related Videos

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
    05:14

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

    Published on: May 16, 2020

    5.4K
    Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
    10:08

    Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

    Published on: February 17, 2018

    14.0K

    Related Experiment Videos

    Last Updated: Feb 14, 2026

    Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
    06:22

    Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

    Published on: November 29, 2024

    1.5K
    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
    05:14

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

    Published on: May 16, 2020

    5.4K
    Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
    10:08

    Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

    Published on: February 17, 2018

    14.0K
  • Successful multidisciplinary management was administered to the patient.
  • The case underscores the critical need for effective PPCM treatment strategies.

    • Implications:

    • Peripartum cardiomyopathy carries significant morbidity and mortality risks.
    • Understanding and managing PPCM is crucial, especially in regions with unknown impact.
    • This case demonstrates the value of a multidisciplinary approach in improving PPCM patient outcomes.